Facty HealthRecognizing the 25 Indicators of Pancreatic Cancer

Read the original article

Pancreatic cancer, affecting approximately 56,000 Americans annually, presents with diverse clinical manifestations that often appear gradually. Early recognition of these indicators proves crucial for improved patient outcomes, as this malignancy frequently remains undetected until advanced stages. The article outlines 25 distinct indicators ranging from common gastrointestinal symptoms to less obvious manifestations such as taste alterations and cognitive changes.

Key Points:

• Primary gastrointestinal indicators include loss of appetite, early satiety, abdominal pain radiating to the back, pale/floating stools, and unexplained weight loss. These symptoms often manifest early in disease progression.
• Metabolic disruptions present as new-onset diabetes in patients over 50, particularly significant as research indicates diabetes presence 1-3 years before cancer diagnosis in many cases.
• Hepatobiliary manifestations include jaundice, pruritus, and enlarged gallbladder due to bile duct obstruction from pancreatic tumors.
• Systemic manifestations encompass fatigue, depression/anxiety, persistent fever, night sweats, and unexpected blood clots (particularly deep vein thrombosis).
• Neurological and sensory changes include peripheral neuropathy, cognitive alterations, vision problems, and notably, altered taste perception, especially regarding tobacco and alcohol.

For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point — to 13% — according to the American Cancer Society’s Cancer Facts & Figures 2024 Report.

More on Pancreatic Cancer